<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37670400</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2332-8886</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Bioelectronic medicine</Title><ISOAbbreviation>Bioelectron Med</ISOAbbreviation></Journal><ArticleTitle>Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome - a case-control study.</ArticleTitle><Pagination><StartPage>19</StartPage><MedlinePgn>19</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42234-023-00121-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Eighty percent of patients infected by SARS-CoV-2 report persistence of one symptom beyond the 4-week convalescent period. Those with orthostatic tachycardia and orthostatic symptoms mimicking postural tachycardia syndrome, they are defined as Long-COVID POTS [LCP]. This case-control study investigated potential differences in autonomic cardiovascular regulation between LCP patients and healthy controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirteen LCP and 16 healthy controls, all female subjects, were studied without medications. Continuous blood pressure and ECG were recorded during orthostatic stress test, respiratory sinus arrhythmia, and Valsalva maneuver. Time domain and power spectral analysis of heart rate [HR] and systolic blood pressure [SBP] variability were computed characterizing cardiac autonomic control and sympathetic peripheral vasoconstriction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">LCP had higher deltaHR (+&#x2009;40&#x2009;&#xb1;&#x2009;6 vs.&#x2009;+&#x2009;21&#x2009;&#xb1;&#x2009;3&#xa0;bpm, p&#x2009;=&#x2009;0.004) and deltaSBP (+&#x2009;8&#x2009;&#xb1;&#x2009;4 vs. -1&#x2009;&#xb1;&#x2009;2 mmHg, p&#x2009;=&#x2009;0.04) upon standing; 47% had impaired Valsalva maneuver ratio compared with 6.2% in controls (p&#x2009;=&#x2009;0.01). Spectral analysis revealed that LCP had lower RMSSD (32.1&#x2009;&#xb1;&#x2009;4.6 vs. 48.9&#x2009;&#xb1;&#x2009;6.8 ms, p&#x2009;=&#x2009;0.04) and HF<sub>RRI</sub>, both in absolute (349&#x2009;&#xb1;&#x2009;105 vs. 851&#x2009;&#xb1;&#x2009;253ms<sup>2</sup>, p&#x2009;=&#x2009;0.03) and normalized units (32&#x2009;&#xb1;&#x2009;4 vs. 46&#x2009;&#xb1;&#x2009;4 n.u., p&#x2009;=&#x2009;0.02). LF<sub>SBP</sub> was similar between groups.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LCP have reduced cardiovagal modulation, but normal sympathetic cardiac and vasoconstrictive functions. Impaired parasympathetic function may contribute to the pathogenesis of Long-COVID POTS syndrome.</AbstractText><CopyrightInformation>&#xa9; 2023. Feinstein Institute for Medical Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rigo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7899-9307</Identifier><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. s.rigo96@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan, 20090, Italy. s.rigo96@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urechie</LastName><ForeName>Vasile</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diedrich</LastName><ForeName>Andr&#xe8;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Luis E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biaggioni</LastName><ForeName>Italo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibao</LastName><ForeName>Cyndya A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL142583</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL157584</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioelectron Med</MedlineTA><NlmUniqueID>101660849</NlmUniqueID><ISSNLinking>2332-8886</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANS</Keyword><Keyword MajorTopicYN="N">HRV</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">POTS</Keyword><Keyword MajorTopicYN="N">Parasympathetic</Keyword><Keyword MajorTopicYN="N">Spectra</Keyword></KeywordList><CoiStatement>C. A. S. is a member of the of RECOVER steering committee funded by NIH. C. A. S. is the chair of the autonomic dysfunction domain of NIH-funded RECOVER. C. A. S. research is founded by American Heart Association grant AHA 967054 &#x201c;Mechanisms Underlying Cardiovascular Consequences Associated with COVID-19 and Long COVID&#x201d;.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37670400</ArticleId><ArticleId IdType="pmc">PMC10481607</ArticleId><ArticleId IdType="doi">10.1186/s42234-023-00121-6</ArticleId><ArticleId IdType="pii">10.1186/s42234-023-00121-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses 11 febbraio. 2023;15(2):508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9962056</ArticleId><ArticleId IdType="pubmed">36851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R, Banerjee A, Baker MR, Dani M, Ford E, Hull JH, et al. Long COVID: mechanisms, risk factors and recovery. Experimental Physiol gennaio. 2023;108(1):12&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm settembre. 2020;17(9):1463&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 1 dicembre. 2020;116(14):2177&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, et al. Immune dysregulation and system pathology in COVID-19. Virulence dicembre. 2021;12(1):918&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993139</ArticleId><ArticleId IdType="pubmed">33757410</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med gennaio. 2021;21(1):e63&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocrit Care giugno. 2021;34(3):1062&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358290</ArticleId><ArticleId IdType="pubmed">32661794</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol gennaio. 2022;23(1):3&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: structure, Biology, and structure-based therapeutics Development. Front Cell Infect Microbiol. 2020;10:587269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723891</ArticleId><ArticleId IdType="pubmed">33324574</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med aprile. 2021;27(4):601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Family Pract 19 gennaio. 2022;39(1):159&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet gennaio. 2021;397(10270):220&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect gennaio. 2021;27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 11 agosto 2020;324(6):603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo JA, Mart&#xed;nez-L&#xf3;pez JP, Carrillo-Lamp&#xf3;n SA, Ruiz-Ojeda D, Herrera-Ram&#xed;rez S, Amezcua-Guerra LM, et al. Post-Acute COVID-19 Symptoms, a Potential Link with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A 6-Month Survey in a Mexican Cohort. Brain Sci. 2021;11(6):760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K, Vanichkachorn G, Cheshire WP, Suarez MD, Shelly S, Lamotte GJ, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res giugno. 2021;31(3):385&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker AM, Brigham E, Connolly B, McPeake J, Agranovich AV, Kenes MT, et al. Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care. Lancet Respir Med novembre. 2021;9(11):1328&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525917</ArticleId><ArticleId IdType="pubmed">34678213</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Mukerji SS, Alabsi HS, Systrom D, Marciano SP, Felsenstein D, et al. Multisystem involvement in Post-Acute Sequelae of Coronavirus Disease 19. Annals of Neurology marzo. 2022;91(3):367&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang L, Yang B, Jiang N, Fu W, He X, Zhou Y, et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020;35(47):e418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7721559</ArticleId><ArticleId IdType="pubmed">33289374</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract ottobre. 2021;75(10):e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M, St&#xe5;hlberg M, Runold M, Nygren-Bonnier M, Nilsson J, Olshansky B, et al. Long-haul Post-COVID-19 symptoms presenting as a variant of Postural Orthostatic Tachycardia Syndrome: the swedish experience. JACC Case Rep aprile. 2021;3(4):573&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, et al. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci novembre. 2021;235:102828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med ottobre. 2019;286(4):438&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 17 novembre. 1998;98(20):2154&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9815870</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Biaggioni I, Yamhure PC, Black BK, Paranjape SY, Byrne DW, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation. 2005;111(13):1574&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">15781744</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob G, Diedrich L, Sato K, Brychta RJ, Raj SR, Robertson D, et al. Vagal and sympathetic function in neuropathic postural tachycardia syndrome. Hypertens maggio. 2019;73(5):1087&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592426</ArticleId><ArticleId IdType="pubmed">30879357</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82(3):308&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res ottobre. 2020;30(5):449&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res aprile. 2021;69(2):205&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal SM, Landers DB, Hollenberg SM, Turi ZG, Glotzer TV, Tancredi J, et al. Prospective evaluation of autonomic dysfunction in Post-Acute Sequela of COVID-19. J Am Coll Cardiol giugno. 2022;79(23):2325&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. Post-COVID-19 Tachycardia Syndrome: a distinct phenotype of Post-Acute COVID-19 syndrome. Am J Med dicembre. 2021;134(12):1451&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VEM, et al. Long-COVID postural tachycardia syndrome: an american Autonomic Society statement. Clin Auton Res giugno. 2021;31(3):365&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques KC, Silva CC, Trindade SDS, Santos MCS, Rocha RSB, Vasconcelos PFDC, Quaresma JAS, Falc&#xe3;o LFM. Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID. Front Cardiovasc Med. 2022;9:862001. 10.3389/fcvm.2022.862001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098798</ArticleId><ArticleId IdType="pubmed">35571200</ArticleId></ArticleIdList></Reference><Reference><Citation>Stute NL, Stickford JL, Province VM, Augenreich MA, Ratchford SM, Stickford ASL. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS&#x2010;CoV&#x2010;2. J Physiol 15 settembre. 2021;599(18):4269&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447023</ArticleId><ArticleId IdType="pubmed">34174086</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah B, Kunal S, Bansal A, Jain J, Poundrik S, Shetty MK, et al. Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing Electrophysiol J aprile. 2022;22(2):70&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8800539</ArticleId><ArticleId IdType="pubmed">35101582</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarcikli LD, Hayiroglu M, Osken A, Keskin K, Kolak Z, Aksu T. Heart rate variability and cardiac autonomic functions in post-COVID period. J Interv Card Electrophysiol aprile. 2022;63(3):715&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8806134</ArticleId><ArticleId IdType="pubmed">35106678</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheldon RS, Grubb BP, Olshansky B, Shen WK, Calkins H, Brignole M, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm giugno. 2015;12(6):e41&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5267948</ArticleId><ArticleId IdType="pubmed">25980576</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. Solomon CG, curatore. N Engl J Med 17 dicembre. 2020;383(25):2451&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">32412710</ArticleId></ArticleIdList></Reference><Reference><Citation>Homan TD, Bordes SJ, Cichowski E, Physiology. Pulse Pressure. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [citato 19 marzo 2023]. Disponibile su: http://www.ncbi.nlm.nih.gov/books/NBK482408/.</Citation><ArticleIdList><ArticleId IdType="pubmed">29494015</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson D. Primer on the Autonomic Nervous System [Internet]. Elsevier; 2012 [citato 17 febbraio 2022]. Disponibile su: https://linkinghub.elsevier.com/retrieve/pii/C20100651868.</Citation></Reference><Reference><Citation>Shaffer F, Ginsberg JP. An overview of Heart Rate Variability Metrics and norms. Front Public Health 28 settembre. 2017;5:258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5624990</ArticleId><ArticleId IdType="pubmed">29034226</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 19961;93(5):1043&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8598068</ArticleId></ArticleIdList></Reference><Reference><Citation>Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation agosto. 1991;84(2):482&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">1860193</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich A, Urechie V, Shiffer D, Rigo S, Minonzio M, Cairo B, et al. Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome. Auton Neurosci dicembre. 2021;236:102886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8939715</ArticleId><ArticleId IdType="pubmed">34634682</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P, Giannetti MP, Weller E, Hamilton MJ, Mukerji SS, Alabsi HS, et al. Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome. Neurol Sci dicembre. 2022;43(12):6627&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9517969</ArticleId><ArticleId IdType="pubmed">36169757</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Chan JFW, Yuen TTT, Shuai H, Yuan S, Wang Y, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe maggio. 2020;1(1):e14&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173822</ArticleId><ArticleId IdType="pubmed">32835326</ArticleId></ArticleIdList></Reference><Reference><Citation>Franca RA, Ugga L, Guadagno E, Russo D, Del Basso De Caro M. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?. APMIS. 2021;129(2):37&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">33098147</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: tissue distribution, Host&#x2013;Virus Interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 1 aprile. 2020;11(7):995&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol gennaio. 2022;42(1):217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Li W, Han J, Zou C, Huang W, Yu W, et al. Angiotensin II induces kidney inflammatory injury and fibrosis through binding to myeloid differentiation protein-2 (MD2) Sci Rep 21 marzo. 2017;7:44911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359637</ArticleId><ArticleId IdType="pubmed">28322341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ, et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proceedings of the National Academy of Sciences. 2006;103(13):5219&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1405626</ArticleId><ArticleId IdType="pubmed">16549778</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli D, McKinley MJ, McAllen RM. The cholinergic anti-inflammatory pathway: a critical review. Auton Neurosci maggio. 2014;182:65&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">24411268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto LE, Raj SR, Gamboa A, Shibao CA, Arnold AC, Garland EM, et al. Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: lessons from postural tachycardia syndrome and obesity. Am J Physiol Heart Circ Physiol. 2015;309(12):H2098&#x2013;2107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4698423</ArticleId><ArticleId IdType="pubmed">26453329</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>